Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis - Concepedia

Concepedia

Publication | Closed Access

Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis

65

Citations

7

References

2021

Year

Alessandro Loglio, Péter Ferenci, Sara Uceda Renteria, C Tham, Caroline Scholtès, Heidemarie Holzmann, Florian van Bömmel, Marta Borghi, Riccardo Perbellini, Alessandro Rimondi,

Journal of Hepatology

HepatologyViral HepatitisHdv-related CirrhosisAntiviral TherapyAcute Liver FailureLiver TransplantationMedicineAutoimmune Liver Disease

References

	Year	Citations

Page 1

Page 1